Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement
About this episode
The episode discusses personalizing treatment targets in psoriatic arthritis based on clinically meaningful improvement thresholds.
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversation explores how patients with differing levels of baseline disease activity may require different degrees of improvement before perceiving treatment benefit, highlighting the potential for more personalised treatment targets and shared decision making in PsA.
More episodes of The IMID Forum
- Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
- Author Interview: Dr Murat Torgutalp, June 2026
- Discussing RA: Infectious complications of RA treatments
- Author Interview: Doctor Chung-Mao Kao, May 2026
Explore listener stats, chart rankings, contacts and more on the The IMID Forum podcast page.